Gene · 1289
Papers3,043
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
61 to 80 of 3,043
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| A novel combination of genomic loci in ITGB2, COL5A1 and VEGFA associated with anterior cruciate ligament rupture susceptibility: insights from Australian, Polish, Swedish, and South African cohorts. | Biol Sport | 2026 | 41668933 | PubTator, text mining | PubMed |
| The Effects of Polystyrene Nanoplastic and Bisphenol A Exposure on the Thyroid Gland in Mice. | Environ Pollut | 2026 | 41638291 | PubTator, text mining | PubMed |
| Transcriptomic analysis reveals the impact of concurrent, resistance, and endurance training on skeletal muscle. | PLoS One | 2026 | 41637404 | PubTator, text mining | PubMed |
| Multiomic analysis of colorectal adenocarcinoma reveals a new subtype of myofibroblastic cancer-associated fibroblasts that express high levels of B7-H3 and have poor-prognosis value. | J Immunother Cancer | 2026 | 41629132 | PubTator, text mining | PubMed |
| Methylome profiling reveals epigenetic alterations in the trabecular meshwork of primary open-angle glaucoma. | Exp Eye Res | 2026 | 41611112 | PubTator, text mining | PubMed |
| Socceromics: A Systematic Review of Omics Technologies to Optimize Performance and Health in Soccer. | Int J Mol Sci | 2026 | 41596414 | PubTator, text mining | PubMed |
| The Genetic and Epigenetic Architecture of Keratoconus: Emerging Pathways and Clinical Implications. | Genes (Basel) | 2026 | 41595486 | PubTator, text mining | PubMed |
| Loss of biomechanical features reveals smooth muscle disruption and disease progression in prostate cancer. | Cancer Cell Int | 2026 | 41559633 | PubTator, text mining | PubMed |
| Histopathological Etiology of Mucoid Degeneration of the Anterior Cruciate Ligament. | Orthop J Sports Med | 2026 | 41552628 | PubTator, text mining | PubMed |
| Engineered atopic dermatitis models for recreating hypoxic conditions in atopic dermatitis microenvironments. | Bioact Mater | 2026 | 41551767 | PubTator, text mining | PubMed |
| Mitochondria dysfunction and increased expression of WNT5A and BNIP3 in tenocytes obtained from patients with tendinopathy. | JSES Int | 2026 | 41550705 | PubTator, text mining | PubMed |
| Elucidating the mechanism of polycyclic aromatic hydrocarbons-induced osteoporosis through network toxicology and molecular docking approaches: BaP as a model compound. | Ecotoxicol Environ Saf | 2026 | 41547189 | PubTator, text mining | PubMed |
| Spatial and single-cell multi-omics reveal pro-angiogenic THY1⁺ fibroblast subtypes predicting prognosis in prostate cancer. | Transl Oncol | 2026 | 41529384 | PubTator, text mining | PubMed |
| Genetic and epigenetic determinants of injury risk and recovery in elite athletes: toward precision sports medicine. | Gene | 2026 | 41391515 | PubTator, text mining | PubMed |
| Platelet defects in patients and mice with Ehlers-Danlos syndrome. | Blood | 2026 | 41284637 | PubTator, text mining | PubMed |
| Characterization of Proteome Features in Patients With Aortic Stenosis Using Data-Independent Acquisition-Based Proteomic Analysis. | Korean Circ J | 2026 | 41044724 | PubTator, text mining | PubMed |
| Modeling glioblastoma in 3D hydrogels enables investigation of Zika virus targeting and immune modulation in oncolytic virotherapy. | Biomater Adv | 2026 | 40957303 | PubTator, text mining | PubMed |
| ALKBH5 modulates COL5A1 mRNA stability via m6A demethylation to promote tobacco carcinogen NNK-induced lung cancer occurrence and progression. | J Adv Res | 2026 | 40812588 | PubTator, text mining | PubMed |
| The Impact of Modern Industrialized Dietary Sodium Intake on the Plasma Proteome. | Am J Hypertens | 2026 | 40327765 | PubTator, text mining | PubMed |
| Bilateral Cranial Cruciate Ligament Rupture Treatment in a Dog Affected by Classical Ehlers-Danlos Syndrome. | Vet Sci | 2025 | 41472142 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/1289/papers?page=4